Showing results (121-130 of 230) with videos related to
Sort By:
Pageof 23
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1987
Expression of a multidrug-resistance gene in human tumors and tissuesA T Fojo, K Ueda, D J Slamon, et al.American Journal of Clinical Oncology|June 1, 1985
Very high dose cyclophosphamide with imidazole carboximide and vincristine sulfate in the treatment of stage IV neuroblastomaU Srinivasan, D Glaubiger, A S Levine, et al.Journal of the National Cancer Institute|July 1, 1983
Heterogeneity of acute lymphocytic leukemia cell surface markers as detected by monoclonal antibodiesD L Mann, B F Haynes, C Thomas, et al.Israel Journal of Medical Sciences|September 1, 1988
Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant sublineN Ramu, A Ramu, D E Cole, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Intrathecal administration of topotecan in nonhuman primatesS M Blaney, D E Cole, K Godwin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Effect of body position on ventricular CSF methotrexate concentration following intralumbar administrationS M Blaney, D G Poplack, K Godwin, et al.Lancet (London, England)|March 24, 1979
Adrenal suppression after short-term corticosteroid therapyR J Spiegel, R A Vigersky, A I Oliff, et al.Acta Endocrinologica|April 1, 1991
Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukemiaT Pasqualini, J McCalla, S Berg, et al.Archives of Pathology & Laboratory Medicine|April 1, 1991
Immunophenotypic analysis of acute lymphoblastic leukemia using routinely processed bone marrow specimensJ K Taubenberger, D E Cole, M Raffeld, et al.Cancer Research|June 15, 1992
Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridineS M Blaney, F M Balis, J Grem, et al.Pageof 23